Related Experiment Video

Updated: Apr 24, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

941

The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression

Yang Wang1, Dan Chen2, Haili Qian3

  • 1Institute of Cancer Stem Cell, Second Affiliated Hospital, Cancer Center, Dalian Medical University, Dalian 116044, China; Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Cancer Cell
|September 10, 2014
PubMed

Insights

The splicing factor RBM4 acts as a tumor suppressor by inhibiting cancer cell growth and migration. Lower RBM4 levels in patients correlate with reduced survival, highlighting its clinical significance.

Area of Science:

  • Molecular biology
  • Cancer research
  • RNA splicing

Background:

  • Splicing dysregulation is a key feature of cancer, but its mechanisms are not fully understood.
  • Alternative splicing alterations contribute to tumor development and progression.

Purpose of the Study:

  • To investigate the role of splicing factor RBM4 in cancer.
  • To elucidate the molecular mechanisms by which RBM4 affects cancer cell behavior and survival.

Main Methods:

  • Investigated RBM4's effect on cancer cell proliferation and migration.
  • Analyzed RBM4's regulation of Bcl-x splicing and its impact on apoptosis.
  • Examined the interaction between RBM4, SRSF1, and mTOR signaling.
  • Correlated RBM4 expression levels with clinical data from cancer patients.

Main Results:

  • RBM4 suppresses proliferation and migration in various cancer cells by controlling cancer-related splicing.
  • RBM4-induced apoptosis is mediated partly through Bcl-x splicing regulation.
  • RBM4 antagonizes SRSF1 to inhibit mTOR activation, a known oncogenic pathway.
  • RBM4 expression is significantly decreased in cancer patients, and higher RBM4 levels correlate with better survival.

Conclusions:

  • RBM4 functions as a tumor suppressor by regulating critical cancer-related splicing events.
  • RBM4's ability to inhibit oncogenic splicing factor SRSF1 and mTOR signaling contributes to its tumor-suppressive role.
  • RBM4 has therapeutic potential and serves as a valuable prognostic biomarker in cancer.

More Related Videos

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

6.6K
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.2K
RNA Splicing01:32

RNA Splicing

15.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K